ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
MIDAZOLAMUM
Active substance (INN) · ATC N05CD08 · 16 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| A05AX04 | MARALIXIBATUM | In force | mentioned in the text | C1-G22 | NO |
| B06AC06 | BEROTRALSTATUM | In force | mentioned in the text | C2-P6.22 | YES |
| N03AX17 | STIRIPENTOLUM | In force | mentioned in the text | C1-G11 | YES |
| N07XX11 | PITOLISANTUM | In force | mentioned in the text | C1-G12 | NO |
| R07AX02 | IVACAFTORUM | In force | mentioned in the text | C2-P6.4 | YES |
| R07AX30 | LUMACAFTORUM+IVACAFTORUM | In force | mentioned in the text | C2-P6.4 | YES |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| BUCCOLAM 10 mg | SOL. BUCOFARINGIANA | 5mg/ml | NEURAXPHARM PHARMACEUTICALS, S.L. - SPANIA | N05CD08 | PS |
| BUCCOLAM 2,5 mg | SOL. BUCOFARINGIANA | 5mg/ml | NEURAXPHARM PHARMACEUTICALS, S.L. - SPANIA | N05CD08 | PS |
| BUCCOLAM 5 mg | SOL. BUCOFARINGIANA | 5mg/ml | NEURAXPHARM PHARMACEUTICALS, S.L. - SPANIA | N05CD08 | PS |
| BUCCOLAM 7,5 mg | SOL. BUCOFARINGIANA | 5mg/ml | NEURAXPHARM PHARMACEUTICALS, S.L. - SPANIA | N05CD08 | PS |
| MIDAZOLAM DESITIN 10 mg | SOL. BUCOFARINGIANA | 5mg/ml | DESITIN ARZNEIMITTEL GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM DESITIN 2,5 mg | SOL. BUCOFARINGIANA | 5mg/ml | DESITIN ARZNEIMITTEL GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM DESITIN 5 mg | SOL. BUCOFARINGIANA | 5mg/ml | DESITIN ARZNEIMITTEL GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM DESITIN 7,5 mg | SOL. BUCOFARINGIANA | 5mg/ml | DESITIN ARZNEIMITTEL GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM HAMELN 1 mg/ml | SOL. INJ./PERF. | 1mg/ml | HAMELN PHARMA GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM HAMELN 2 mg/ml | SOL. INJ./PERF. | 2mg/ml | HAMELN PHARMA GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM HAMELN 5 mg/ml | SOL. INJ./PERF. | 5mg/ml | HAMELN PHARMA GMBH - GERMANIA | N05CD08 | PS |
| MIDAZOLAM HYPERICUM 5 mg/ml | SOL. INJ./PERF. | 5mg/ml | HYPERICUM S.R.L. - ROMANIA | N05CD08 | PS |
| MIDAZOLAM PANPHARMA 1 mg/ml | SOL INJ./PERF. | 1mg/ml | PANPHARMA - FRANTA | N05CD08 | PS |
| MIDAZOLAM PANPHARMA 5 mg/ml | SOL INJ./PERF. | 5mg/ml | PANPHARMA - FRANTA | N05CD08 | PS |
| MIDAZOLAM SUN 1 mg/ml | SOL. INJ./PERF. IN SERINGA PREUMPLUTA | 1mg/ml | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | N05CD08 | PS |
| MIDAZOLAM SUN 2 mg/ml | SOL. INJ./PERF. IN SERINGA PREUMPLUTA | 2mg/ml | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | N05CD08 | PS |